ApoE −491A/T Promoter Polymorphism is not an Independent Risk Factor, but Associated with the ε4 Allele in Hungarian Alzheimer’s Dementia Population

By Juhász Anna   Palotás András   Janka Zoltán   Rimanóczy Ágnes   Palotás Miklós   Bódi Nikoletta   Boda Krisztina   Zana Marianna   Vincze Gábor   Kálmán János  

Neurochemical Research, Vol. 30, Iss. 5, 2005-05 ,pp. : 591-596

Springer Publishing Company

Access to resources Recommend Favorite

Increased Alzheimer’s Disease Neuropathology is Associated with Type 2 Diabetes and ApoE ε4 Carrier Status

By  

Current Alzheimer Research, Vol. 10, Iss. 6, 2013-01 ,pp. : 654-659

Bentham Science Publishers

Access to resources Recommend Favorite

The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE ε4 allele increases the risk of late-onset Alzheimer disease

By Wang Binbin   Jin Feng   Yang Ze   Lu Zeping   Kan Rui   Li Shu   Zheng Chenguang   Wang Li  

Journal of Molecular Neuroscience, Vol. 30, Iss. 3, 2006-10 ,pp. : 267-271

Humana Press, Inc

Access to resources Recommend Favorite

A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson’s disease

By Multhammer Manuel   Michels Andreas   Zintl Maria   Mendoza Maria   Klünemann Hans-Hermann  

Acta Neurologica Belgica, Vol. 114, Iss. 1, 2014-03 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

No association of CSF biomarkers with APOE ε 4, plaque and tangle burden in definite Alzheimer's disease

By Engelborghs Sebastiaan  

Brain, Vol. 130, Iss. 9, 2007-09 ,pp. : 2320-2326

Oxford University Press

Access to resources Recommend Favorite